Ciapponi, Agustín, et al. “Trastuzumab-Emtansine Versus Other Anti-HER2 Regimens in Early or Unresectable or Metastatic HER2 Positive Breast Cancer: Systematic Review and Network Meta-Analysis”. Revista Peruana De Medicina Experimental Y Salud Pública, vol. 41, no. 1, Mar. 2024, pp. 7-18, https://doi.org/10.17843/rpmesp.2024.411.13351.